ECM
ONCS

ExodusPoint Capital Management’s OncoSec Medical Incorporated ONCS Stock Holding History

ExodusPoint Capital Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,480
Closed -$155K – 3073
2021
Q1 		$155K Buy
1,480
+623
+73% +$85.3K ﹤0.01% 1915
2020
Q4 		$122K Buy
+857
New +$91.4K ﹤0.01% 1810

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

ExodusPoint Capital Management's ONCS Position: Q2 2021 in Review

ExodusPoint Capital Management sold out of OncoSec Medical Incorporated (ONCS) in Q2 2021, closing a stake of 1,480 shares — an estimated $155K sold.

ExodusPoint Capital Management first reported a position in ONCS in Q4 2020 and held it in 2 quarters. The position peaked at $155K in Q1 2021. 35 funds tracked by Wall St. Rank hold ONCS as of Q2 2021.

  • ExodusPoint Capital Management reported no remaining OncoSec Medical Incorporated position as of Q2 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 1,480 OncoSec Medical Incorporated shares in Q2 2021, an estimated $155K.
  • ExodusPoint Capital Management first reported a position in OncoSec Medical Incorporated in Q4 2020 and held it in 2 quarters.
  • ExodusPoint Capital Management's OncoSec Medical Incorporated position peaked at $155K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.